Cargando…

Activating transcription factor 3: A potential therapeutic target for inflammatory pulmonary diseases

BACKGROUND: Activating transcription factor 3 (ATF3) is a nuclear protein that is widely expressed in a variety of cells. It is a stress‐inducible transcription gene and a member of the activating transcription factor/cAMP responsive element‐binding protein (ATF/CREB) family. METHODS: The comprehens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dandan, Jing, Juanjuan, Dong, Xue, Zhang, Chenyang, Wang, Jia, Wan, Xianyao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515505/ https://www.ncbi.nlm.nih.gov/pubmed/37773692 http://dx.doi.org/10.1002/iid3.1028

Ejemplares similares

Transcription factors and potential therapeutic targets for pulmonary hypertension
por: Yang, Liu, et al.
Publicado: (2023)

Release and Actions of Inflammatory Exosomes in Pulmonary Emphysema: Potential Therapeutic Target of Acupuncture
por: Zou, Yao, et al.
Publicado: (2021)

Human herpesvirus 7 encephalitis in an immunocompetent adult and a literature review
por: Li, Yi, et al.
Publicado: (2022)

Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022)

Revealing novel pyroptosis-related therapeutic targets for sepsis based on machine learning
por: Chen, Ying, et al.
Publicado: (2023)

circRNA: Regulatory factors and potential therapeutic targets in inflammatory dermatoses
por: Liu, Ruifeng, et al.
Publicado: (2022)

Transcription factor Nrf2 as a potential therapeutic target for COVID-19
por: Wang, Yifan, et al.
Publicado: (2022)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas
por: Liu, Tieju, et al.
Publicado: (2020)

Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets
por: Sabol, Maja, et al.
Publicado: (2018)

Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension
por: Dong, Li, et al.
Publicado: (2014)

Transcription Factors in Eosinophil Development and As Therapeutic Targets
por: Fulkerson, Patricia C.
Publicado: (2017)

Ceramides: a potential therapeutic target in pulmonary emphysema
por: Tibboel, Jeroen, et al.
Publicado: (2013)

Transcription Factors with Targeting Potential in Gliomas
por: Giannopoulou, Angeliki-Ioanna, et al.
Publicado: (2022)

Transcription Factors as Targets of Natural Compounds in Age-Related Diseases and Cancer: Potential Therapeutic Applications
por: Kim, Mi Eun, et al.
Publicado: (2022)

Exploration of potential therapeutic targets for stroke based on the GEO database
por: Ma, Li-Zhong, et al.
Publicado: (2021)

Transcription Factors as Therapeutic Targets in Chronic Kidney Disease
por: Hishikawa, Akihito, et al.
Publicado: (2018)

Targeting transcription factors for therapeutic benefit in rheumatoid arthritis
por: Balendran, Thivya, et al.
Publicado: (2023)

Anti-Transcription Factor RNA Aptamers as Potential Therapeutics
por: Mondragón, Estefanía, et al.
Publicado: (2016)

Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension
por: He, Wenjun, et al.
Publicado: (2022)

Nosip is a potential therapeutic target in hepatocellular carcinoma cells
por: Gao, Junjie, et al.
Publicado: (2023)

MARCKS as a Potential Therapeutic Target in Inflammatory Breast Cancer
por: Manai, Maroua, et al.
Publicado: (2022)

Stress granules: potential therapeutic targets for infectious and inflammatory diseases
por: Li, Wenyuan, et al.
Publicado: (2023)

Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
por: Leng, Yiming, et al.
Publicado: (2021)

Semaphorins as Potential Immune Therapeutic Targets for Cancer
por: Jiang, Jun, et al.
Publicado: (2022)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
por: Prakash, Annamneedi Venkata, et al.
Publicado: (2023)

Transcription Factors in Heart: Promising Therapeutic Targets in Cardiac Hypertrophy
por: Kohli, Shrey, et al.
Publicado: (2011)

SOXC Transcription Factors as Diagnostic Biomarkers and Therapeutic Targets for Arthritis
por: Ahmed, Emad A., et al.
Publicado: (2023)

Pulmonary Inflammatory Response in Lethal COVID-19 Reveals Potential Therapeutic Targets and Drugs in Phases III/IV Clinical Trials
por: López-Cortés, Andrés, et al.
Publicado: (2022)

HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
por: Plowright, L, et al.
Publicado: (2009)

Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
por: Jiang, Li-Ping, et al.
Publicado: (2022)

Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Furuya, Yoshiaki, et al.
Publicado: (2010)

Therapeutic potential of targeting kinase inhibition in patients with idiopathic pulmonary fibrosis
por: Kim, Suji, et al.
Publicado: (2020)

STAT3 signaling in ovarian cancer: a potential therapeutic target
por: Liang, Renba, et al.
Publicado: (2020)

Proteinase 3; a potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases
por: Crisford, Helena, et al.
Publicado: (2018)

Characterization of the Inflammatory Microenvironment and Identification of Potential Therapeutic Targets in Wilms Tumors()()
por: Maturu, Paramahamsa, et al.
Publicado: (2014)

Pattern recognition receptors as potential therapeutic targets in inflammatory rheumatic disease
por: Mullen, Lisa M, et al.
Publicado: (2015)

Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets
por: Santana, Patricia Teixeira, et al.
Publicado: (2022)

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
por: Singh, Harbinder, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b5n3jga2k25r3r55tsehcuk7on